Journal
NATURE MEDICINE
Volume 8, Issue 5, Pages 500-508Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm0502-500
Keywords
-
Funding
- NIAID NIH HHS [AI35761] Funding Source: Medline
- NINDS NIH HHS [NS11920, NS08953] Funding Source: Medline
- PHS HHS [18235, 30201, 41402, 28579] Funding Source: Medline
Ask authors/readers for more resources
Microarray analysis of multiple sclerosis (MS) lesions obtained at autopsy revealed increased transcripts of genes encoding inflammatory cytokines, particularly interleukin-6 and -17, interferon-gamma and associated downstream pathways. Comparison of two poles of MS pathologyacute lesions with inflammation versus 'silent' lesions without inflammation-revealed differentially transcribed genes. Some products of these genes were chosen as targets for therapy of experimental autoimmune encephalomyelitis (EAE) in mice. Granulocyte colony-stimulating factor is upregulated in acute, but not in chronic, MS lesions, and the effect on ameliorating EAE is more pronounced in the acute phase, in contrast to knocking out the immunoglobulin Fc receptor common gamma chain where the effect is greatest on chronic disease. These results in EAE corroborate the microarray studies on MS lesions. Large-scale analysis of transcripts in MS lesions elucidates new aspects of pathology and opens possibilities for therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available